Echocardiographic assessment of intravenous administration of medetomidine and xylazine hydrochloride at different sedative doses in one-humped camel calves (Camelus dromedarious)

Document Type : Original Article

Authors

1 Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran

3 HIV/STI Surveillance Research Center, WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Echocardiography illustrates a convenient and noninvasive tool for measuring cardiac output (CO) changes after administration of sedative drugs, but it is unknown in camelids practice. The aim of present study was to investigate echocardiographic effects of intravenous (IV) injection of medetomidine and xylazine in camel calves. Twenty apparently healthy immature male one-humped camel calves (Camelus dromedarious) were divided into four groups (five animals in each treatment). Medetomidine and xylazine were injected into the left jugular vein at two different doses of 10.00 and 20.00 μg kg-1 and 0.20 and 0.40 mg kg-1, respectively. Effects on some selected echocardiographic parameters were recorded at different intervals, before drug administrations (baseline) and after 3, 60 and 120 min. Data were analyzed by repeated measure, ANOVA test, then relevance and significance were taken as p ≤ 0.05. Significant decrease in fractional shortening percentage (FS%), ejection fraction percentage (EF%), stroke volume (SV), heart rate (HR) and subsequent CO were noticeable 3 min after drug administration in medetomidine high dose (MH), medetomidine low dose (ML) and xylazine high dose (XH) groups (p ≤ 0.05), furthermore at this time significant decrease in left ventricular mass (LVmass) and left ventricular systolic time intervals were seen in these groups, however, in xylazine low dose (XL) group, the lowest level of most echocardiographic parameters were detectable after 60 min. High dose IV injection of medetomidine was associated with significant decrease in most echocardiographic parameters without echocardiographic arrhythmia. Although, ML and XH groups had the same effects on echocardiographic indices but the intensity and duration were less than MH group.

Keywords


  1.  

    1. England GC, Clarke KW. Alpha 2 adrenoreceptor agonists in the horse- - a review. Br Vet J 1996; 152(6): 641-657.
    2. Kinjavdekar P, Singh Amarpal GR, Aithal HP, et al. Physiologic and biochemical effects of subarachnoidally administrated xylazine and medetomidine in goats. Small Rum Res 2000; 38(3): 217-228.
    3. Al-Mubarak AI, Abdin-Bey M, Ramadan RO. A retrospective clinical evaluation of xylazine-ketamine total intravenous anesthesia (TIVA) in dromedary camels. J Camel Pract Res 2008; 15: 201-203.
    4. Cruz JI, Loste JM, Burzaco OH. Observations on the use of medetomidine/ketamine and its reversal with atipamezole for chemical restraint in the mouse. Lab Anim 1998; 32(1): 18-22.
    5. Scheinin M, MacDonald E. An introduction to the pharmacology of alpha 2- adrenoceptors in the central nervous system. Acta Vet Scand Suppl 1989; 85: 11-19.
    6. Dugdale A. Veterinary anesthesia: Principles to practice. Oxford, UK: Willey-Blackwell, 2010; 39.
    7. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998; 27(6): 612-622.
    8. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive proprieties in the dog. Vet Anaesth Analg 2005; 32(3): 117-127.
    9. Paddleford RR, Harvey RC. Alpha 2 Agonists and antagonists. Vet Clin North Am Small Anim Pract 1999; 29(3): 737-745.
    10. Dart CM. Advantages and disadvantages of using alpha-2 agonists in veterinary practice. Aust Vet J 1999; 77(11): 720-721.
    11. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993; 7(4): 247-252.
    12. Reef VB. Echocardiographic examination in the horse: the basics. Compend Contin Educ Pract Vet 1990; 12: 1312-1319.
    13. Hallowell GD, Potter TJ, Bowen IM. Methods and normal values for echocardiography in adult dairy cattle. J Vet Cardiol 2007; 9(2): 91-98.
    14. Buczinski S. Cardiovascular ultrasonography in cattle. Vet Clin North Am: Food Anim Pract 2009; 25(3):
      611-632.
    15. Fowler ME. Medicine and surgery of camelids. 3rd ed. Iowa, USA: Willey-Blackwell Publishing 2010; 423-427.
    16. McConachie E, Barton MH, Rapoport G, et al. Doppler and volumetric echocardiographic methods for cardiac output measurement in standing adult horses. J Vet Intern Med 2013; 27(2): 324-330.
    17. Tibby SM, Murdoch IA. Measurement of cardiac output and tissue perfusion. Curr Opin Pediatr, 2002; 14(3):303-309.
    18. Braun U, Schweizer Determination of heart dimensions in cattle via 2-D-mode echocardiography [German]. Berl Munch Tierarztl Wochenschr 2001; 114(1-2): 46-50.
    19. Zarifi M, Buczinski S, Rezakhani A, et al. Effect of lactation on functional and morphological echocardiographic variables in adult dairy cows. J Vet Cardiol 2012; 14(3): 415-421.
    20. Tharwat M, Al-Sobayil F, Ali A, et al. Echocardiography of the normal camel (Camelus dromedaries) heart: technique and cardiac dimensions. BMC Vet Res 2012; 8: 130. doi: 10.1186/1746-6148-8-130.
    21. Al-Taher AY, Zabady MK, Almubarak A, et al. Clinical use of tramadol and xylazine in dromedary camel undergoing soft tissue surgeries. J Anim Vet Adv 2014; 13: 206-208.
    22. Wagner AE, Muir WW 3rd, Hinchcliff KW. Cardiovascular effects of xylazine and detomidine in horses. Am J Vet Res 1991; 52(5): 651-657.
    23. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 74(3): 581-605.
    24. Masoudifard M, Esmailinejad MR, Sakhaee E, et al. Pulsed wave Doppler echocardiographic assessment after sedation by intravenous injection of medetomidine and xylazine hydrochloride on cardiac output and systolic time intervals in one-humped camel calves (Camelus dromedarious). Iran J Vet Res 2020; 21(4): 257-262.
    25. Sinclair MD. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 2003; 44(11): 885-897.
    26. Bueno AC, Cornick-Seahorn J, Seahorn TL, et al. Cardiopulmonary and sedative effects of intravenous administration of low doses of medetomidine and xylazine to adult horses. Am J Vet Res 1999; 60(11): 1371-1376.
    27. Marcilla M, Schauvliege S, Duchateau L, et al. Cardiopulmonary effects of two constant rate infusions of dexmedetomidine in isoflurane anaesthetized ponies. Vet Anaesth Anal 2010; 37(4):311-21.
    28. Bettschart-Wolfensberger R, Kalchofner K, Neges K, et al. Total intravenous anaesthesia in horses using medetomidine and propofol. Vet Anaesth Analg 2005; 32(6): 348-354.
    29. Bryant CE, Clarke KW, Thompson J. Cardiopulmonary effects of medetomidine in sheep and in ponies. Res Vet Sci 1996; 60(3): 267-271.
    30. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57(6):450-458.
    31. Markus MR, Freitas HF, Chizzola PR, et al. Left ventricular mass in patients with heart failure. Arq Bras Cardiol 2004; 83(3): 227-231.
    32. Sousa MG, Carareto R, De-Nardi AB, et al. Effects of isoflurane on Tei-index of myocardial performance in healthy dogs. Can Vet J 2007; 48(3): 277-282.
    33. Saponaro V, Crovace A, De Marzo L, et al. Echocardiographic evaluation of the cardiovascular effects of medetomidine, acepromazine and their combination in healthy dogs. Res Vet Sci 2013; 95(2): 687-692.